BRIEF-Knight Therapeutics enters into agreement for $200 mln bought deal of common shares

Wed May 11, 2016 7:47am EDT
Email This Article |
Share This Article
  • Facebook
  • LinkedIn
  • Twitter
| Print This Article
[-] Text [+]

May 11 (Reuters) - Knight Therapeutics

* Bought deal agreement pursuant to which underwriters agreed to purchase 25 million shares of company at $8.00 per common share

* Knight therapeutics enters into agreement for a $200 million bought deal of common shares Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1-646-223-8780)